Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer

International Journal of Cancer

Volumn 92, Issue 5, 2001, Pages 671-677

  Seidl, J ^b   Rauch, J ^b   Krieg, R C ^a   Appel, S ^b   Baumgartner, R ^a   Knuechel, R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

5 Aminolevulinic acid; Flow cytometry; Fluorescence microscopy; JC 1; Mitochondria; Phase contrast microscopy; Photodynamic therapy; Phototoxicity; Protoporphyrin IX

Indexed keywords

ACRIDINE ORANGE; AMINOLEVULINIC ACID; PROPIDIUM IODIDE; PROTOPORPHYRIN;

ARTICLE; BLADDER CARCINOMA; BRONCHUS MUCOSA; CANCER STAGING; CELL DAMAGE; CELL KILLING; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; MITOCHONDRION; PHOTODYNAMICS; PHOTOTOXICITY; PRIORITY JOURNAL; UROTHELIUM;

AMINOLEVULINIC ACID; FLOW CYTOMETRY; HUMANS; MITOCHONDRIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; TUMOR CELLS, CULTURED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0035371845     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010601)92:5<671::AID-IJC1240>3.0.CO;2-P     Document Type: Article

References (32)

1. Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells
2. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: Implications for photodynamic therapy
3. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: A pharmacokinetic study
4. Photosensitization of the rat endometrium following 5-aminolevulinic acid induced photodynamic therapy
5. A comparison of functional bladder damage after intravesical photodynamic therapy with three different photosensitizers
6. Functional and histological damage in the mouse bladder after photodynamic therapy
7. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid
8. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results
9. 5-Aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors
10. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
11. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis
12. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): Mechanisms and clinical results
13. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors
14. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: Growth, chromosome pattern and ultrastructure
15. Immortalisation of human urothelial cells
16. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro
17. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid
18. Photophysical and photobiological processes in the photodynamic therapy of tumours
19. The photobiology of photodynamic therapy: Cellular targets and mechanisms
20. Singlet molecular oxygen in micellar systems. I. Distribution equilibria between hydrophobic and hydrophilic compartments
21. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen
22. The role of subcellular localization in initiation of apoptosis by photodynamic therapy
23. Subcellular phototoxicity of 5-aminolaevulinic acid (ALA)
24. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy
25. The induction of apoptosis by a positively charged methylene blue derivative
26. Photodynamic therapy: A mitochondrial inducer of apoptosis
27. A comet assay of DNA damage and repair in K562 cells after photodynamic therapy using haematoporphyrin derivative, methylene blue and meso-tetrahydroxyphenylchlorin
28. Subcellular damage kinetics within co-cultivated WI38 and VA13-transformed WI38 human fibroblasts following 5-aminolevulinic acid-induced protoporphyrin IX formation
29. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
30. Photodynamic therapy of rat bladder and urethra: Evaluation of urinary and reproductive function after inducing protoporphyrin IX with 5-aminolaevulinic acid
31. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: Light diffusion and histological changes
32. Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line